2025-11-24 - Analysis Report
Okay, here's a comprehensive analysis of Lam Research (LRCX) based on the data provided, broken down into sections as requested:

**1) Return Rate Comparison & Alpha/Beta Analysis:**

*   **Company Overview:** Lam Research Corp. designs, manufactures, markets, and services semiconductor processing equipment used in the fabrication of integrated circuits.
*   **Return Rate:** LRCX significantly outperformed the S&P 500 (VOO) over the period considered.
    *   LRCX Cumulative Return: 198.05%
    *   VOO Cumulative Return: 94.64%
    *   Divergence: 103.4 (Relative Divergence: 73.4)
*   **Analysis:** Lam Research has delivered substantially higher returns than the market. The divergence indicates that while there have been periods of underperformance, the recent performance puts it in the top quartile of its historical relative performance against the S&P 500.

    **Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 84.0%  | 67.8% | 56.0% | 0.1  | 23.2   |
| 2016-2018  | 18.0%  | 68.1% | 3.0%  | 0.0  | 17.2   |
| 2017-2019  | 53.0%  | 82.9% | 30.0% | 1.1  | 36.9   |
| 2018-2020  | 66.0%  | 82.9% | 42.0% | 1.1  | 59.5   |
| 2019-2021  | 119.0% | 82.9% | 73.0% | 1.0  | 90.7   |
| 2020-2022  | -10.0% | 79.2% | -9.0% | 0.9  | 53.0   |
| 2021-2023  | -13.0% | 80.4% | -15.0% | 1.0  | 98.8   |
| 2022-2024  | -52.0% | 80.4% | -72.0% | 1.0  | 91.1   |
| 2023-2025  | 109.0% | 80.4% | 50.0% | 0.9  | 179.9  |

*   **CAGR:** The Compound Annual Growth Rate shows significant volatility, with both very high growth periods (e.g., 2019-2021) and sharp declines (e.g., 2022-2024).
*   **MDD:** The Maximum Drawdown is consistently high, indicating that the stock experiences substantial price declines from peak to trough. This implies a higher level of risk.
*   **Alpha:** A positive Alpha indicates outperformance relative to the benchmark (risk-adjusted). Negative Alpha indicates underperformance. The Alpha fluctuates significantly, reflecting periods of both substantial outperformance and underperformance.
*   **Beta:** The Beta is generally around 1, indicating that the stock's volatility is similar to the overall market. However, in 2015-2018 the Beta was below 1, implying it was less sensitive to market fluctuations.
*   **Cap:** Market capitalization in Billion.

**2) Recent Stock Price Fluctuations:**

*   Close: 142.65
*   Previous Close: 139.59
*   Change: 2.19
*   5-day SMA: 144.35
*   20-day SMA: 155.92
*   60-day SMA: 137.71

*   **Analysis:**
    *   The current price is below both the 5-day and 20-day Simple Moving Averages (SMA), suggesting a recent downtrend.
    *   The 5-day SMA is below the 20-day SMA, further supporting this downtrend.
    *   However, the current price is above the 60-day SMA, indicating that the longer-term trend is still upward.
    *   The recent change of 2.19 suggests a slight positive movement today.

**3) RSI, PPO, & Market Risk Indicators:**

*   MRI: 0.8 (Medium Investment)
*   RSI: 35.00
*   PPO: -2.13
*   Hybrid Signal: cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   Recent (20 days) relative divergence change: -4.9 (-): 단기하락
*   Expected Return (%): 28.6

*   **Analysis:**
    *   **MRI:** A Market Risk Indicator of 0.8 suggests a medium level of investment risk.
    *   **RSI:** The RSI of 35.00 indicates that the stock is nearing oversold conditions, which could suggest a potential buying opportunity.
    *   **PPO:** The negative PPO (-2.13) indicates that the short-term moving average is below the long-term moving average, suggesting a downtrend.
    *   **Hybrid Signal:** The hybrid signal recommends buying 100% of available cash, considering the current condition is very safe, but the date to consider it to decide the Cash Ratio is 2025-11-03.
    *   **Relative Divergence Change:** The negative change in relative divergence over the past 20 days reinforces the short-term downward trend.
    *   **Expected Return:** The relatively high expected return (28.6%) suggests that analysts anticipate significant future growth, potentially making it attractive for long-term investors.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **Key Themes:** The recent news articles suggest a mixed outlook for Lam Research:
    *   **Positive:** Discussions about catalysts that could drive the stock higher and the opening of a new facility indicate growth potential. The high price surge in 2025.
    *   **Negative/Cautious:** Articles question if it's too late to invest after a price surge, discuss potential setbacks, and report a reduced stock position by an investment firm.

**4-2) Analyst Opinions:**

*   **Consensus:**
    *   Rating: Buy (Mean: 1.74)
    *   Number of Opinions: 30
    *   Target Price: Average 158.69, High 200.00, Low 84.00

*   **Analysis:** The analyst consensus is generally positive, with a "Buy" rating and a significant number of opinions. The average target price of 158.69 suggests potential upside from the current price of 142.65. The high target price of 200.00 indicates that some analysts are very optimistic about the stock's future performance. The low target price of 84.00 suggests potential downside risk.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-24 | 1.24 | 5.32 B$    |
| 2025-04-25 | 1.04 | 4.72 B$    |
| 2025-01-31 | 0.93 | 4.38 B$    |
| 2024-10-28 | 0.86 | 4.17 B$    |
| 2025-10-24 | 0.86 | 4.17 B$    |

*   **Analysis:**
    *   Both EPS (Earnings Per Share) and Revenue have generally been increasing over the past few quarters, indicating positive growth momentum.
    *   The most recent EPS (1.24) is significantly higher than previous quarters, suggesting strong performance.
    *   The revenue has been steadily growing to the current level of 5.32 Billion.

**6) Financial Information (Revenue, Profitability & Capital):**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $5.32B    | 50.43%         |
| 2025-06-30   | $5.17B    | 50.08%         |
| 2025-03-31   | $4.72B    | 49.02%         |
| 2024-12-31   | $4.38B    | 47.37%         |
| 2024-09-30   | $4.17B    | 48.05%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30   | $10.19B   | 15.39%   |
| 2025-06-30   | $9.86B    | 17.44%   |
| 2025-03-31   | $9.51B    | 13.99%   |
| 2024-12-31   | $8.81B    | 13.52%   |
| 2024-09-30   | $8.47B    | 13.18%   |

*   **Analysis:**
    *   **Revenue and Profitability:** Revenue has been consistently increasing, and the profit margin is remarkably high, consistently above 47% and recently over 50%. This demonstrates strong operational efficiency and pricing power.
    *   **Capital and Profitability:** Equity has grown steadily, reflecting the company's increasing value. Return on Equity (ROE) is also strong, indicating efficient use of shareholder equity to generate profits. ROE has fluctuated slightly but remains at a healthy level.

**7) Comprehensive Analysis (Summary):**

Lam Research presents a mixed picture.

*   **Strengths:**
    *   **Strong Historical Performance:** Significant outperformance compared to the S&P 500.
    *   **Positive Growth Trends:** Increasing revenue, EPS, and equity. High profit margins.
    *   **Positive Analyst Sentiment:**  Consensus "Buy" rating with a decent upside target price.
    *   **Oversold Potential:** RSI nearing oversold territory suggesting a potential buying opportunity.
*   **Weaknesses/Risks:**
    *   **High Volatility:** High Maximum Drawdown indicates significant price swings.
    *   **Recent Downtrend:** Price below short-term SMAs and negative change in relative divergence.
    *   **Mixed News Sentiment:**  Some articles suggest caution and potential setbacks.
    *   **Beta around 1:**  Implies systematic risk (market risk), so not much diversification benefit can be gained by including LRCX in a portfolio.

*   **Overall:** Lam Research is a fundamentally strong company in the semiconductor industry with significant growth potential. However, the stock exhibits high volatility and is currently experiencing a short-term downtrend. The analyst consensus is positive, and the expected return is attractive. Investors should be aware of the risks associated with the stock's volatility and the cyclical nature of the semiconductor industry. Given the mixed signals, a cautious approach with careful monitoring of market conditions and company-specific news is recommended. The MRI of 0.8 suggests that it's a medium-risk investment, suitable for investors with a moderate risk tolerance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.